Clinical Trial Update: A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for ALN-HTT02 in adults with Huntington's disease. The study is currently recruiting and has not reported results yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• ALN-HTT02

Snippet

Sponsor: Alnylam Pharmaceuticals | Conditions: Huntington's Disease | Phase 1 | Status: RECRUITING